Epithelial-mesenchymal transitions in cancer progression.
about
GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transitionAutocrine PDGFR signaling promotes mammary cancer metastasisMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersThe plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion.Echoes of a distant past: The cag pathogenicity island of Helicobacter pyloriDesmosomes in acquired diseaseInhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancerPhosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells.Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells.Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment.Regulation of tensin-promoted cell migration by its focal adhesion binding and Src homology domain 2.Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cellsStaurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulationThe stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.Analysis of differentially expressed proteins in cancerous and normal colonic tissues.Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility.Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.Transcriptional regulation of stromelysin-1 gene expression is altered during progression of mouse mammary epithelial cells from functionally normal to malignant.TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cellsThe dominance of the microenvironment in breast and ovarian cancer.Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversionMatrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development.High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapyE/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesisMatrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors.Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCCThe myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine.Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cellsGenetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epitheliumProteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression.The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.Histone modifications: Targeting head and neck cancer stem cells.Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines.The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavityNeural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients.Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors.
P2860
Q24301339-8941377C-A8B4-42A4-862C-7E938D14FD18Q24545375-071E2F0E-DD2B-418D-969D-E3F29E501845Q24674085-789495E0-1FE5-4B94-8334-A7F4F0D17905Q24801456-2B28D440-6344-4F5E-B0C5-4C6F3A75D0C8Q26865877-D50F17A6-CD69-48A5-A129-914E3404D599Q27025901-C003CC0F-895D-4D7F-B716-5A8756B4EDB7Q28488474-1526B4F3-7F16-4D31-85A1-1805C389CE31Q30175229-91392058-A9CB-4A2A-8079-4D4368040349Q30476325-200A2B02-20C9-401E-BEDF-A8490FA7B64DQ30502337-271244D1-DF60-46F0-B6CB-AD1020DC34A1Q30757298-80510CF1-EB1B-4FD3-8BA1-0ED238D8A087Q33351988-345D76B0-8C41-4ED7-B299-A24ECD1C1B0AQ33482559-62FE8175-D9D0-45AB-9F52-6EB0F18E033FQ33783677-30BB2CDD-EAF9-4F2C-9FA0-190BB397E2F7Q33860861-DE1CDF44-39CC-489A-9FD5-F0A18AB7CD40Q33866128-0EA66E54-DE9E-42DC-92E5-3C9F447B05A5Q33913667-B2E890CC-B385-4717-B317-7B9C66438701Q33966952-F4F89EDE-FEAC-4F89-A358-EDA4E3BBF1E8Q34103350-70D4D548-BECF-4DC0-8C19-C6DEDF73566CQ34224634-7D3168F5-3174-4794-A87C-4E7E01FDA989Q34654993-63CC2486-9227-4544-B4AE-E4778A22F1ABQ34764852-CE03F05A-DA55-4B1A-AE07-2964FDAB93E1Q35581768-D71F18E8-4CA4-466F-8B80-387C2C319D9CQ35633688-EE80E4CC-1B03-46A1-A340-FF4F2FFE7627Q35653917-0C6B0C90-0647-49C2-ADE0-996DF369D175Q35757384-9E66C2B6-BEE1-41C4-91DD-D8457D12593AQ36255048-C6C0B96E-CF4D-42E9-8554-6CC4C9BD7CCBQ36643993-6B1A6CD3-8DCB-4A6F-A5CE-E30E298C0C3DQ37046518-00171DAE-1849-4A2E-8636-E4F13B578281Q37053170-E198AE8E-2C7B-46E5-8461-26A6AADC1E9AQ37118924-9C14487E-191D-4AF4-B8A7-D0DB5ADF35BFQ37184986-70D3DA28-6678-4170-9E65-486C93CF8257Q37202994-7FBA3607-8180-49B9-8379-334960A4A08CQ37307440-6E0219B8-6397-4A11-8CFA-77B22B03F5C1Q38255668-0229590F-5870-43BD-B31A-01842D554979Q38271597-E002840C-92B9-4497-B131-CC363D353DBDQ38292527-58CF3FC0-6D4F-4493-9693-6861EB66A427Q38308993-2FCA169E-F0C9-496E-9A99-23CEAEE67A46Q38309443-3C817210-28F4-4FA0-AEA1-54F9F6AC43ADQ39460658-0913769A-98C5-44F0-B562-E785DA0F17F3
P2860
Epithelial-mesenchymal transitions in cancer progression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Epithelial-mesenchymal transitions in cancer progression.
@en
type
label
Epithelial-mesenchymal transitions in cancer progression.
@en
prefLabel
Epithelial-mesenchymal transitions in cancer progression.
@en
P2093
P1433
P1476
Epithelial-mesenchymal transitions in cancer progression.
@en
P2093
Birchmeier C
Birchmeier W
Brand-Saberi B
P304
P577
1996-01-01T00:00:00Z